Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Phase 2a Single Dose Study in Patients With Alcohol Use Disorder

NCT05674929 is registered in ClinicalTrials.gov with Beckley Psytech Limited as lead sponsor.

NCT NCT05674929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05674929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Phase 2a Single Dose Study in Patients With Alcohol Use Disorder
Lead sponsor
Beckley Psytech Limited
Phase
Phase 2
Overall status
Completed
Start date
May 30, 2023
Completion date
October 2, 2024
Enrollment
13 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder